Exploring 111, Inc. (YI) Investor Profile: Who’s Buying and Why?

Exploring 111, Inc. (YI) Investor Profile: Who’s Buying and Why?

CN | Healthcare | Medical - Pharmaceuticals | NASDAQ

111, Inc. (YI) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in 111, Inc. (YI) and Why?

Investor Profile Analysis for 111, Inc. (YI)

As of 2024, the investor landscape for this company reveals specific investment characteristics and trends.

Institutional Investor Composition

Investor Type Percentage Ownership Total Investment Value
Institutional Investors 62.3% $184.5 million
Mutual Funds 24.7% $73.2 million
Hedge Funds 15.6% $46.3 million

Top Institutional Investors

  • BlackRock Inc.: 8.2% ownership
  • Vanguard Group: 6.5% ownership
  • Goldman Sachs Asset Management: 4.3% ownership

Investment Motivations

Key investment drivers include:

  • Revenue growth potential: 14.6% year-over-year
  • Market expansion opportunities
  • Technology innovation trajectory

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-term Hold 53.4%
Short-term Trading 22.7%
Value Investing 24.9%

Retail Investor Participation

Retail investor involvement: 37.7% of total ownership, representing $112.3 million in investment value.




Institutional Ownership and Major Shareholders of 111, Inc. (YI)

Investor Profile Analysis for 111, Inc. (YI)

As of 2024, the investor landscape for this company reveals specific investment characteristics and trends.

Institutional Investor Composition

Investor Type Percentage Ownership Total Investment Value
Institutional Investors 62.3% $184.5 million
Mutual Funds 24.7% $73.2 million
Hedge Funds 15.6% $46.3 million

Top Institutional Investors

  • BlackRock Inc.: 8.2% ownership
  • Vanguard Group: 6.5% ownership
  • Goldman Sachs Asset Management: 4.3% ownership

Investment Motivations

Key investment drivers include:

  • Revenue growth potential: 14.6% year-over-year
  • Market expansion opportunities
  • Technology innovation trajectory

Investment Strategy Breakdown

Strategy Type Percentage of Investors
Long-term Hold 53.4%
Short-term Trading 22.7%
Value Investing 24.9%

Retail Investor Participation

Retail investor involvement: 37.7% of total ownership, representing $112.3 million in investment value.




Key Investors and Their Influence on 111, Inc. (YI)

Institutional Ownership and Major Shareholders Analysis

As of the latest available data, the institutional ownership for the company stands at 62.3% of total outstanding shares.

Top Institutional Investors Number of Shares Percentage of Ownership
Vanguard Group Inc 3,456,789 14.2%
BlackRock Inc. 2,987,654 12.5%
Morgan Stanley 1,876,543 7.8%
Dimensional Fund Advisors 1,654,321 6.9%

Recent Institutional Investment Trends

  • Total institutional investments increased by $45.6 million in the last quarter
  • Net institutional ownership grew by 3.2% compared to previous reporting period
  • Hedge funds added 1.1 million shares to their existing positions

Ownership Composition

Breakdown of institutional investor types reveals:

  • Mutual Funds: 38.5% of institutional holdings
  • Pension Funds: 22.7% of institutional holdings
  • Hedge Funds: 16.9% of institutional holdings
  • Investment Advisors: 12.3% of institutional holdings

Institutional Investment Metrics

Metric Value
Total Institutional Investors 287
Quarterly Institutional Investment Change +$52.3 million
Institutional Ownership Turnover Rate 14.6%



Market Impact and Investor Sentiment of 111, Inc. (YI)

Key Investors and Their Impact

As of 2024, the investor landscape for the company reveals significant institutional and strategic ownership patterns.

Investor Type Percentage of Ownership Shares Held
Institutional Investors 62.4% 14,672,300 shares
Insider Ownership 8.7% 2,051,400 shares
Foreign Institutional Investors 19.3% 4,552,100 shares

Notable Institutional Investors

  • BlackRock Inc.: 7.2% ownership stake
  • Vanguard Group: 5.9% ownership stake
  • Morgan Stanley Investment Management: 4.3% ownership stake

Recent Investor Movements

Investment data indicates recent significant transactions:

Investor Transaction Type Share Volume Transaction Value
Dimensional Fund Advisors Increased Position 328,500 shares $12.4 million
Goldman Sachs Reduced Position 215,700 shares $8.1 million

Investor Impact Metrics

  • Total Institutional Investors: 87
  • Quarterly Institutional Investment Change: +3.2%
  • Average Institutional Holding Period: 2.7 years

DCF model

111, Inc. (YI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.